Diagnosis: Primary Aldosteronism (Suspected)
The clinical triad—resistant hypertension, hypokalemia, and elevated aldosterone-to-renin ratio (ARR = 18/0.3 = 60, normal <20)—is highly suggestive of primary aldosteronism. The next step is confirmatory testing before subtype localization.
Confirmatory Test: Saline Suppression Test
Key Point
The 0.9% saline suppression test is the gold-standard confirmatory test for primary aldosteronism.
High-YieldNEET PG
Saline suppression is the most specific confirmatory test because it directly tests the kidney's ability to suppress aldosterone in response to sodium loading and volume expansion.
Why Saline Suppression Over Captopril?
| Test | Mechanism | Sensitivity | Specificity | Use |
|---|
| Saline suppression | Volume expansion → ↓ renin → ↓ aldosterone | 90% | 95% | Gold standard for confirmation |
| Captopril challenge | ACE inhibition → ↑ renin → ↓ aldosterone | 85% | 80% | Alternative; less specific |
Clinical Pearl
Captopril test is less reliable because some aldosterone-producing adenomas can show paradoxical aldosterone rise with ACE inhibition. Saline suppression is more physiologically sound and reproducible.
Investigation Sequence for Primary Aldosteronism
Loading diagram...
When to Use Adrenal Venous Sampling
Key Point
Adrenal venous sampling (AVS) is NOT a confirmatory test; it is a subtype localization test used AFTER primary aldosteronism is confirmed. AVS determines whether the aldosterone excess is from a unilateral adenoma (surgical candidate) or bilateral hyperplasia (medical management).